Ļoti svaigs pētījums. LSD microdosing in major depressive disorder: results from an open-label trial. https://www.sciencedirect.com/science/article/pii/S0028390825004708

Izskatās cerīgi. While limited by an open-label design and small sample size, this study provides preliminary evidence supporting the safety and feasibility of treating moderate depression with microdosed LSD and underscores a need for further randomised controlled trials.

P. s. Man ir aizdomas, ka antidepresanti ražotājiem šis varētu nepatikt.